Symposia

[2S08m] FAONS Symposium
Unlocking Hope : Viral vector-mediated gene therapy for neurological disorders-A promising frontier in therapeutic advancements and future prospects

Thu. Jul 25, 2024 8:45 AM - 10:45 AM Room 8 (413+414)

Organizer: Pike-See Cheah (University Putra Malaysia, Malaysia)

+Add all to schedule

[2S08m-Introduction] Introduction

[2S08m-01] Development and delivery of candidate genome editing therapies for eye and brain diseases

*Paul Thomas^1,2, Ashleigh Geiger^1,2, Stefka Tasheva^1,2, Lachlan Staker^1,2, Jesse Kennedy^1,2, Michaela Scherer^1,2, Sandra Piltz^1,2, Fatwa Adikusuma^1,2 (1. University of Adelaide, Adelaide, Australia, 2. South Australian Health & Medical Research Institute, Adelaide, Australia)

[2S08m-02] AAV mediated gene therapy through the ages – treating childhood Batten disease gives clues to strategies for Alzheimer’ disease.

*Stephanie M Hughes¹, Wickliffe C Abraham², Bruce M Mockett², Yuanyuan Emily He^1,2 (1. Department of Biochemistry, University of Otago, 2. Department of Psychology, University of Otago)

[2S08m-03] Oncolytic viruses engineered to enforce cholesterol efflux revive TAM-T cells-mediated antitumor immunity and a phase I clinical trial in glioblastoma

*Jiwu Wei¹, Shiqun Wang^1,2, Wei Yan³, Lingkai Kong¹, Jie Dong¹ (1. Sch Med, Nanjing Univ, Nanjing, China, 2. Chin Acad Sci, Hangzhou, China, 3. Neurosurg, 2nd Aff Hosp, Sch Med, Zhejiang Univ, Hang Zhou, China)

[2S08m-04] Gene replacement therapy in a schwannomamouse
model of neurofibromatosis type 2

*Pike See Cheah^1,2, Shilpa Prabhakar², Xandra Breakefield² (1. Universiti Putra Malaysia, 2. Massachusetts General Hospital, Harvard Medical School, Boston, USA)

[2S08m-Discussion] Discussion

[2S08m-ClosingRemarks] Closing Remarks

Session information

[2S08m] FAONS Symposium
Unlocking Hope : Viral vector-mediated gene therapy for neurological disorders-A promising frontier in therapeutic advancements and future prospects

[2S08m-Introduction] Introduction

[2S08m-01] Development and delivery of candidate genome editing therapies for eye and brain diseases

[2S08m-02] AAV mediated gene therapy through the ages – treating childhood Batten disease gives clues to strategies for Alzheimer’ disease.

[2S08m-03] Oncolytic viruses engineered to enforce cholesterol efflux revive TAM-T cells-mediated antitumor immunity and a phase I clinical trial in glioblastoma

[2S08m-04] Gene replacement therapy in a schwannomamouse
model of neurofibromatosis type 2

[2S08m-Discussion] Discussion

[2S08m-ClosingRemarks] Closing Remarks

Authentication

Session information

[2S08m] FAONS SymposiumUnlocking Hope : Viral vector-mediated gene therapy for neurological disorders-A promising frontier in therapeutic advancements and future prospects

[2S08m-Introduction] Introduction

[2S08m-01] Development and delivery of candidate genome editing therapies for eye and brain diseases

[2S08m-02] AAV mediated gene therapy through the ages – treating childhood Batten disease gives clues to strategies for Alzheimer’ disease.

[2S08m-03] Oncolytic viruses engineered to enforce cholesterol efflux revive TAM-T cells-mediated antitumor immunity and a phase I clinical trial in glioblastoma

[2S08m-04] Gene replacement therapy in a schwannomamousemodel of neurofibromatosis type 2

[2S08m-Discussion] Discussion

[2S08m-ClosingRemarks] Closing Remarks

Authentication

[2S08m] FAONS Symposium
Unlocking Hope : Viral vector-mediated gene therapy for neurological disorders-A promising frontier in therapeutic advancements and future prospects

[2S08m-04] Gene replacement therapy in a schwannomamouse
model of neurofibromatosis type 2